Fiji Series Delivers Plasma and Thermal Atomic Layer Deposition for Flexible Research

Cambridge NanoTech, the world leader in Atomic Layer Deposition (ALD) science and equipment for research and industry, today announced the launch of its first line of plasma ALD systems, the Fiji Series.

Cambridge NanoTech Fiji Plasma ALD System (Photo: Business Wire)

“The Fiji is a breakthrough in ALD system design,” said Dr. Jill Becker, Founder and CEO of Cambridge NanoTech. “We built it from the ground up for the specific purpose of plasma ALD, but with the ability to conduct thermal ALD as well.”

Built on the success of the Savannah, the Fiji delivers unparalleled flexibility and ease of experimental use for plasma ALD research. “We are pleased to announce that the success of the Fiji thus far includes the delivery of ten Fiji systems on three continents,” said Dr. Becker.

The Fiji will be on display at ALD 2009 conference in Monterey, CA during the week of July 19th and can be seen by visiting Cambridge NanoTech in booth #10 at the Portola Hotel. In addition, Cambridge NanoTech scientists will present the first peer-reviewed papers based on research performed on the Fiji.

Cambridge NanoTech focuses on simplifying the science of atomic layer deposition for customers worldwide — from universities to the largest corporations — by delivering comprehensive services and versatile, turnkey systems that are accessible, affordable and accurate to the atomic scale. Cambridge NanoTech, founded in 2003, grew directly out of Gordon Lab at Harvard University, one of the foremost ALD research groups in the world.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.